Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Technical Support for Birth Defects and Developmental Disabilities Prevention Education Efforts, Contract Solicitation Number (CSN) 2006-N-08835, 16370 [E7-6270]
Download as PDF
16370
Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices
pharmacies, doctors’ offices, and
community centers.
In the Fall of 2005, the Spanish
language campaign was pilot tested by
5 state health departments that receive
funding from CDC for their arthritis
programs. CDC will eventually
disseminate these materials to all 36
CDC will conduct an evaluation of the
impact of the Spanish language health
communications campaign on the
exercise/physical activity-related
attitudes, beliefs, and behaviors among
the target audience of Spanish-speaking
people with arthritis. There are no costs
to the respondents other than their time.
CDC-funded states. The 5 preliminary
pilot tests focused on reach and
exposure; a more thorough evaluation is
necessary to assess impact of the
campaign. This information will be used
to guide the public health practice of the
36 state arthritis programs and their
partners.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Screening Survey ............................................................................................
Telephone Survey ............................................................................................
12,000
2,500
1
1
2/60
15/60
400
625
Total ..........................................................................................................
........................
........................
........................
1,025
Dated: March 28, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–6276 Filed 4–3–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jlentini on PROD1PC65 with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Technical
Support for Birth Defects and
Developmental Disabilities Prevention
Education Efforts, Contract Solicitation
Number (CSN) 2006–N–08835
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned SEP:
Time and Date: 12 p.m.–3 p.m., April
30, 2007 (Closed).
Place: Teleconference, Centers for
Disease Control and Prevention, 1600
Clifton Road, NE., Atlanta, GA 30333.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters to be Discussed: The meeting
will include the review, discussion, and
evaluation of applications received in
response to CSN 2006–N–08835,
‘‘Technical Support for Birth Defects
and Developmental Disabilities
Prevention Education Efforts.’’
VerDate Aug<31>2005
17:57 Apr 03, 2007
Jkt 211001
For Further Information Contact:
Christine Morrison, Ph.D., Scientific
Review Administrator, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., Mailstop D72, Atlanta,
GA 30333, Telephone 404.639.3098.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: March 28, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–6270 Filed 4–3–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Preparation for International
Conference on Harmonisation
Meetings in Brussels, Belgium; Public
Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of meeting.
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public meeting entitled ‘‘Preparation for
ICH Meetings in Brussels, Belgium’’ to
provide information and receive
comments on the International
Conference on Harmonisation (ICH) as
well as the upcoming meetings in
Brussels, Belgium. The topics to be
discussed are the topics for discussion
at the forthcoming ICH steering
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
committee meeting. The purpose of the
meeting is to solicit public input prior
to the next steering committee and
expert working groups meetings in
Brussels, Belgium May 5–10, 2007, at
which discussion of the topics
underway and the future of ICH will
continue.
Date and Time: The meeting will be
held on Friday April 6, 2007, from 3:30
p.m. to 5 p.m.
Location: The meeting will be held at
5600 Fishers Lane, third floor,
Conference Room G, Rockville, MD
20857. For security reasons, all
attendees are asked to arrive no later
than 3:20 p.m., as you will be escorted
from the front entrance of 5600 Fishers
Lane to Conference Room G.
Contact Person: Michelle Limoli,
Office of the Commissioner (HFG–1),
Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857,
301–827–0908, e-mail:
michelle.limoli@fda.hhs.gov, FAX: 301–
827–0003.
Registration and Requests for Oral
Presentations: Send registration
information (including name, title, firm
name, address, telephone, and fax
number), written material, and requests
to make oral presentations, to the
contact person by April 5, 2007.
If you need special accommodations
due to a disability, please contact
Michelle Limoli as soon as possible.
SUPPLEMENTARY INFORMATION: The ICH
was established in 1990 as a joint
regulatory/industry project to improve,
through harmonization, the efficiency of
the process for developing and
registering new medicinal products in
Europe, Japan, and the United States
without compromising the regulatory
obligations of safety and effectiveness.
In recent years, many important
initiatives have been undertaken by
regulatory authorities and industry
E:\FR\FM\04APN1.SGM
04APN1
Agencies
[Federal Register Volume 72, Number 64 (Wednesday, April 4, 2007)]
[Notices]
[Page 16370]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6270]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Technical Support for Birth Defects and
Developmental Disabilities Prevention Education Efforts, Contract
Solicitation Number (CSN) 2006-N-08835
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
SEP:
Time and Date: 12 p.m.-3 p.m., April 30, 2007 (Closed).
Place: Teleconference, Centers for Disease Control and Prevention,
1600 Clifton Road, NE., Atlanta, GA 30333.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of applications received in response to CSN
2006-N-08835, ``Technical Support for Birth Defects and Developmental
Disabilities Prevention Education Efforts.''
For Further Information Contact: Christine Morrison, Ph.D.,
Scientific Review Administrator, Centers for Disease Control and
Prevention, 1600 Clifton Road NE., Mailstop D72, Atlanta, GA 30333,
Telephone 404.639.3098. The Director, Management Analysis and Services
Office, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both CDC and the Agency for Toxic Substances
and Disease Registry.
Dated: March 28, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-6270 Filed 4-3-07; 8:45 am]
BILLING CODE 4163-18-P